Lewes, DE -- (SBWire) -- 09/06/2013 --LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: AMARANTUS BIOSCIENCE HOLDINGS, INC.(OTCBB:AMBS), Nissan Motor Co., Ltd. (ADR)(OTCMKTS:NSANY), Creative Edge Nutrition Inc(OTCMKTS:FITX), LIMITLESS VENTURE(OTCMKTS:LVGI).

AMARANTUS BIOSCIENCE HOLDINGS, INC.(OTCBB:AMBS) ended higher +10.19% and complete the day at $0.0595. The total number of shares changed hands during the day was 6.19 million. After opening at $0.0547, the stock hit as high as $0.0629. However, it traded between $0.01 and $0.20 over the last twelve months.

Amarantus BioScience Holdings, Inc., a development-stage biotechnology company, focuses on the discovery and development of drug candidates and diagnostic blood tests to diagnose and treat human diseases in the United States

For How Long AMBS will Fight for Profitability? Read This Trend Analysis report

Nissan Motor Co., Ltd. (ADR)(OTCMKTS:NSANY) closed yesterday at $20.61, a +0.59% increase. Around 253,243 shares were traded, beating an-average trading volume of 103,412 shares. The company is now valued at around $ 43.19B.

Nissan Motor Co., Ltd., together, with its subsidiaries, manufactures and sells automotive products and marine equipment primarily in Japan, the People?s Republic of China, North America, and Europe. It offers passenger cars, zero emission vehicles, compacts, sedans, sport vehicles, minivans, wagons, crossovers, small utility vehicles, pickup trucks, light commercial vehicles, and forklifts, as well as engages in sales financing activities

For How Long NSANY Gloss will Attract Investors? Find out via this report

Creative Edge Nutrition Inc(OTCMKTS:FITX) moved +8.33 percent higher at $0.0013 and traded between $0.0012 and $0.0018 after opening the day at $0.0013. Its performance stands at -18.75% for a month. Going back further than one month, 1-year performance after recent close was -70.45%.

Creative Edge Nutrition, Inc. focuses on the development of health?oriented nutrition products. The company offers a range of capsules, tablets, and powders, as well as science based products in the categories of weight management, nutrition challenges, energy, and fitness

For How Long FITX Gloss will Attract Investors? Find out via this report

LIMITLESS VENTURE(OTCMKTS:LVGI) shares fall, losing -41.99 percent to close at $0.0210. The stock is up around 133.33% this year and -47.5% for the last 12 months. Around 3.33 million shares changed hands yesterday, higher from an-average trading volume of 277,478 shares.

Limitless Venture Group Inc., together with its subsidiaries, engages in the production, distribution and marketing of wellness, anti-aging, and hormone replacement therapy products for males and females in the OTC nutraceutical sector.

Will LVGI Get Buyers Even After The Recent Rally? Find Out Here

About LeadingStockAlerts
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.

Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.

Disclaimer
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/